Heart Failure
Conditions
Keywords
CRT, HEART FAILURE
Brief summary
The registry is designed to determine the long-term mortality and morbidity benefit as a result of Cardiac Resynchronization Therapy with Defibrillation (CRT-D) vs. Implantable Cardioverter Defibrillator (ICD) therapy in the MADIT-CRT study patient population. The registry will collect data on patients that previously participated at MADIT-CRT sites within Europe through five years of participation from their orginal enrollment in the MADIT-CRT IDE study.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Active patients who were enrolled in the MADIT-CRT IDE within Europe
Exclusion criteria
Patients who are unable or unwilling to comply with the protocol requirements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality | 36 month follow-up |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Heart failure event or death | 36 month follow-up | The combined end point of heart-failure or death, whichever came first. |
Countries
Israel